Project measures / variables set:   Boon1   survival

ID, description, units MPD:46921   survival   survival (days to death, max 30)   [d]  
influenza A (H5N1) virus study
Measures
• dosage group:    • low    • medium    • high
Data set, strains Boon1   inbred   23 strains     sex: f     age: 6-9wks
Procedure health assessment
Comparisonmultiple dosage cohorts but no control group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Boon1 - survival (days to death, max 30)




  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
dose 2 14665.2348 7332.6174 150.3955 < 0.0001
strain 15 28433.609 1895.5739 38.8791 < 0.0001
dose:strain 30 5210.9219 173.6974 3.5626 < 0.0001
Residuals 710 34616.4559 48.7556

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Boon1 46921 health assessment influenza A (H5N1) virus survival (days to death, max 30)   [d]   dose group: low  survival_lo inbred 18 f 6-9wks
Boon1 46922 health assessment influenza A (H5N1) virus survival (days to death, max 30)   [d]   dose group: medium  survival_med inbred 22 f 6-9wks
Boon1 46923 health assessment influenza A (H5N1) virus survival (days to death, max 30)   [d]   dose group: high  survival_hi inbred 21 f 6-9wks